ECO 2026 12 - 15 May 2026

Time to sustainable weight reduction thresholds with semaglutide 7.2 mg in adults with obesity: A post hoc analysis of the STEP UP trial

Authors :

Georgia Argyrakopoulou¹; Christine S. Fuchs Jacobsen²; Swathi Gopal³; Deborah. Horn⁴; Maria Quiroga⁵; John B. Buse⁶

Affiliations

View Details Hide Details

{{ getPageNum(PDFPage) }}

Keywords

Obesity

Congress oral presentation

GLP-1 RA

Semaglutide

PHASE 3 (RCT)